CRNO B
0.15 SEK
-0.03 (-16.53%)
Sten R. Sörensen

Advancing pipeline with purpose

Interim Report Q3 2026

“These advances reflect the growing maturity of our pipeline, and across three differentiated programs, our focus is on measurable clinical, regulatory and preclinical milestones.”

Sten R. Sörensen

CEO

Financial Calendar

View all
Year-end report 2026

Financial Reports

View all

04 Nov 2026

Cereno Scientific Publishes Interim Report for Q3 2026

26 Aug 2026

Cereno Scientific Publishes Interim Report for Q2 2026

27 May 2026

Cereno Scientific Publishes Interim Report for Q1 2026

Press releases

View all

20 Nov 2026

Cereno Scientific invites shareholders and investors to a digital investor meeting and Q&A

18 Nov 2026

Cereno Scientific Achieves Key Clinical Milestone as First Patient Is Dosed in Global Phase IIb EPIMODE Trial of CS1 in PAH

17 Nov 2026

Cereno Scientific announces resignation of Chairperson of the Board at his own request

Featured highlights

View all

Analyst report

12 Jan 2026

Cereno Scientific - Entering a value inflection phase

An outlook by Jyoti Prakesh, Edison.

Analysts

New analyst coverage

Leading global investment bank Stifel has initiated equity research coverage of the company in March 2026. The initiation reflects growing external interest in the company.

Presentation

Capital Markets Day 2026

A recording of the company's CMD held on February 5, 2026.

Corporate governance

Governance

Corporate governance

Cereno Scientific is committed to high standards of corporate governance, transparency, and accountability. Our governance framework supports responsible decision-making, long-term value creation, and trust among shareholders and stakeholders.

We adhere to applicable regulations and best practices for companies listed on Nasdaq First North Growth Market.

Explore more

Investors

Email notifications

Stay up to date

Driving excellence

Contact

Investor questions

Tove Bergenholt, Head of IR & Communications
Email: [email protected]
Phone: +46(0)732-366 246

Learn more